Evidence map›Paper›PMID 34622278›Full record

ArticleJournal of biochemistry2022

Structural insights into the enhanced thermostability of cysteine substitution mutants of L-histidine decarboxylase from Photobacterium phosphoreum.

Yuki Oda, Kunio Nakata, Hiroshi Miyano, Toshimi Mizukoshi, Hiroki Yamaguchi, Tatsuki Kashiwagi

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Journal of biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yuki OdaAjinomoto Co., Inc., Kawasaki, Kanagawa 210-8681, Japan.
Kunio NakataAjinomoto Co., Inc., Kawasaki, Kanagawa 210-8681, Japan.
Hiroshi MiyanoAjinomoto Co., Inc., Kawasaki, Kanagawa 210-8681, Japan.
Toshimi MizukoshiAjinomoto Co., Inc., Kawasaki, Kanagawa 210-8681, Japan.
Hiroki YamaguchiAjinomoto Co., Inc., Kawasaki, Kanagawa 210-8681, Japan.
Tatsuki KashiwagiAjinomoto Co., Inc., Kawasaki, Kanagawa 210-8681, Japan.
Ajinomoto (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Enzymatic amino acid assays are important in physiological research and clinical diagnostics because abnormal amino acid concentrations in biofluids are associated with various diseases. L-histidine decarboxylase from Photobacterium phosphoreum (PpHDC) is a pyridoxal 5'-phosphate-dependent enzyme and a candidate for use in an L-histidine quantitation assay. Previous cysteine substitution experiments demonstrated that the PpHDC C57S mutant displayed improved long-term storage stability and thermostability when compared with those of the wild-type enzyme. In this study, combinational mutation experiments of single cysteine substitution mutants of PpHDC were performed, revealing that the PpHDC C57S/C101V/C282V mutant possessed the highest thermostability. The stabilizing mechanism of these mutations was elucidated by solving the structures of PpHDC C57S and C57S/C101V/C282V mutants by X-ray crystallography. In the crystal structures, two symmetry-related PpHDC molecules form a domain-swapped homodimer. The side chain of S57 is solvent exposed in the structure, indicating that the C57S mutation eliminates chemical oxidation or disulfide bond formation with a free thiol group, thereby providing greater stability. Residues 101 and 282 form hydrophobic interactions with neighboring hydrophobic residues. Mutations C101V and C282V enhanced thermostability of PpHDC by filling a cavity present in the hydrophobic core (C101V) and increasing hydrophobic interactions.

Indexed as

CysteineHistidine DecarboxylaseHistidinePhotobacteriumCysteineHistidineHistidine DecarboxylaseAbbreviations: AADCs, amino acid decarboxylase; ASA, accessible surface area; CL, catalytic loop; HDC, L-histidine decarboxylase; HDH, histamine dehydrogenase; HsHDC, HDC from humans; LL, long loop; 1-methoxy PMS, 1-methoxy-5-methylphenazinium methylsulfate; MjTDC, tyrosine decarboxylase from Methanocaldococcus jannaschii; MR, molecular replacement; PLP, pyridoxal 5′-phosphate; PpHDC, L-histidine decarboxylase from Photobacterium phosphoreum; PpHDC-SM, PpHDC C57S mutant; PpHDC-TM, PpHDC C57S/C101V/C282V mutant; (WST)-8, water-soluble tetrazolium salt; WT, wild-typecrystal structurehistidine decarboxylaseprotein engineeringthermostabilitythermostable mutant

Identifiers

PMID34622278
OpenAlexW3201686620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.